Nuclear medicine imaging of infection in cancer patients (with emphasis on FDG-PET)
C. Bleeker-Rovers, F. Vos, W. van der Graaf and W. OyenArticles
Oncologist
2011
980--991
Radiolabeled cetuximab: dose optimization for epidermal growth factor receptor imaging in a head-and-neck squamous cell carcinoma model
B. Hoeben, J. Molkenboer-Kuenen, W. Oyen, W. Peeters, J. Kaanders, J. Bussink and O. BoermanArticles
IJC
2011
870--878
Impaired fetal growth and low plasma volume in adult life
R. Scholten, W. Oyen, M. der Van Vlugt, A. Van Dijk, M. Hopman, F. Lotgering and M. SpaandermanArticles
Obstet Gynecol
2011
1314--1322
Evaluation of CCK2 receptor binding ligands: the inheritance of Thomas Behr
O. Boerman and L. AlojArticles
EJNMMI
2011
1407--1409
Consequences of epidermal growth factor receptor (ErbB1) loss for vascular smooth muscle cells from mice with targeted deletion of ErbB1
B. Schreier, M. Döhler, S. Rabe, B. Schneider, G. Schwerdt, S. Ruhs, M. Sibilia, M. Gotthardt, M. Gekle and C. GrossmannArticles
ATVB
2011
1643--1652
Immuno-PET of cancer: a revival of antibody imaging
O. Boerman and W. OyenArticles
JNM
2011
1171--1172
EUS-FNA for the detection of left adrenal metastasis in patients with lung cancer
O. Schuurbiers, K. Tournoy, H. Schoppers, B. Dijkman, H. Timmers, L. de Geus-Oei, J. Grefte, K. Rabe, P. Dekhuijzen, H. van der Heijden and J. AnnemaArticles
LUNGC
2011
310--315
Titin visualization in real time reveals an unexpected level of mobility within and between sarcomeres
K. da Silva Lopes, A. Pietas, M. Radke and M. GotthardtArticles
JCELBIO
2011
785--798
Adjuvant radioimmunotherapy after radiofrequency ablation of colorectal liver metastases in an experimental model
G. de Jong, T. Hendriks, G. Franssen, W. Oyen, O. Boerman and R. BleichrodtArticles
EJSURONC
2011
258--264
Experimental study of radioimmunotherapy versus chemotherapy for colorectal cancer
G. de Jong, R. Bleichrodt, A. Eek, W. Oyen, O. Boerman and T. HendriksArticles
BJS
2011
436--441
Adjuvant radioimmunotherapy improves survival of rats after resection of colorectal liver metastases
G. de Jong, T. Hendriks, A. Eek, W. Oyen, I. Nagtegaal, R. Bleichrodt and O. BoermanArticles
AOSURG
2011
336--341
Preclinical evaluation of 68Ga-DOTA-minigastrin for the detection of cholecystokinin-2/gastrin receptor-positive tumors
M. Brom, L. Joosten, P. Laverman, W. Oyen, M. Béhé, M. Gotthardt and O. BoermanArticles
MOLI
2011
144--152
18F-FDG PET as a predictor of pulmonary function in sarcoidosis
R. Keijsers, E. Verzijlbergen, J. van den Bosch, P. Zanen, E. van de Garde, W. Oyen and J. GruttersArticles
Sarcoidosis Vasc Diffuse Lung Dis
2011
123--129
PET and SPECT in osteomyelitis and prosthetic bone and joint infections: a systematic review
W. van der Bruggen, C. Bleeker-Rovers, O. Boerman, M. Gotthardt and W. OyenArticles
SEMNM
2010
3--15
18F-FLT PET/CT for early response monitoring and dose escalation in oropharyngeal tumors
E. Troost, J. Bussink, A. Hoffmann, O. Boerman, W. Oyen and J. KaandersArticles
JNM
2010
866--874
Histopathologic validation of 3'-deoxy-3'-18F-fluorothymidine PET in squamous cell carcinoma of the oral cavity
E. Troost, J. Bussink, P. Slootweg, W. Peeters, M. Merkx, A. van der Kogel, W. Oyen and J. KaandersArticles
JNM
2010
713--719
PET-CT for response assessment and treatment adaptation in head and neck cancer
J. Bussink, C. van Herpen, J. Kaanders and W. OyenArticles
LANCETO
2010
661--669
Innovations in radiotherapy planning of head and neck cancers: role of PET
E. Troost, D. Schinagl, J. Bussink, O. Boerman, A. van der Kogel, W. Oyen and J. KaandersArticles
JNM
2010
66--76
Correlation of segmented metabolic tumor volume with outcome--letter
E. Troost, D. Schinagl, J. Bussink, J. Kaanders, W. Oyen and O. BoermanArticles
CLINCR
2010
1968; author reply 1968--1968; author reply 1969
Clinical evidence on PET-CT for radiation therapy planning in head and neck tumours
E. Troost, D. Schinagl, J. Bussink, W. Oyen and J. KaandersArticles
RTO
2010
328--334